TRIRX SPEKE LTD

13436320 liquidation London Manufacturing
2
Cases
3
Practitioners
3
Directors

Company overview

Company number 13436320
Type ltd
Status liquidation
Incorporated 2021-06-03
Registered office London, EC1A 4HD
Industry Manufacturing
SIC codes 21200

About the company

Trirx Speke Ltd is a London company incorporated in 2021. Its registered activity is manufacture of pharmaceutical preparations.

Insolvency timeline

10 Sep 2025
wound up on · Creditors' voluntary liquidation
10 Sep 2025
administration ended on · Administration
12 Sep 2024
administration started on · Administration

Directors (3)

Director Appointed Ceased to act
Keith Anthony Lyon Current Director 03 Jun 2021
James Louis Scandura Current Director 03 Jun 2021
Timothy Cyril Tyson Current Director 03 Jun 2021

Insolvency practitioners

practitioner
Appointed: 2025-09-10
practitioner
Appointed: 2025-09-10
practitioner
Appointed: 2025-09-10

Track any company

Create a free account to follow any UK company and get an email the moment a new insolvency filing appears.

Get started free

Who is InsolvencyRadar for?

Built for everyone who works with UK insolvency data

Credit & risk teams

Monitor your customers and suppliers, and get alerted the moment one enters an insolvency process.

Insolvency practitioners & advisers

Track appointments, benchmark against peers and spot new cases in your region as they are filed.

Investors, lawyers & researchers

Analyse market trends, distressed sectors and recovery opportunities across the whole UK.

Simple, transparent pricing

Full access to every UK company insolvency, with alerts, exports and the appointed practitioner on every case.

Monthly subscription

£199 /month

Ideal for businesses and law firms.

Unlock all data
  • Real-time insolvency feed
  • Appointed practitioner on every case
  • Unlimited watchlists and email alerts
  • Industry and region filters
  • CSV export
Best value

Lifetime

£1,999 £2,499

One payment, lifetime access.

Get lifetime access
  • Everything in the monthly plan
  • Lifetime access (no recurring fees)
  • Monthly insolvency report
  • Full historical database